Literature DB >> 9548942

Investigation of the cooperative structure of Fc fragments from myeloma immunoglobulin G.

V M Tischenko1, V M Abramov, V P Zav'yalov.   

Abstract

The cooperative structure of Fc fragments prepared from myeloma human IgG1 was studied using scanning microcalorimetry and fluorescence at pH 4.2-8.0. It was shown that the first to be melted are CH2 domains whose interaction with each other is rather weak, while that with CH3 domains is strong. Then CH3 domains which form a single cooperative block are melted. The data for the structure of the Fc fragment in solution agree with the X-ray data according to which the interaction between CH2 domains is mediated by the carbohydrate moiety while the two CH3 domains are strongly associated. The presence of intensive CH2-CH3 interaction is a distinctive feature of the state of the Fc fragment in the given pH region as compared to that at pH <4.1 [Tischenko, V. M., et al. (1982) Eur. J. Biochem. 126, 517-521; Ryazantsev, S., et al. (1990) Eur. J. Biochem. 190, 393-399]. First, cis interactions greatly increase the free energy of the native structure stabilization in CH2 domains. Second, they decrease this energy for CH3 domains when compared to the state of the latter at pH 3.8 or within the Fc' fragment (the dimer of CH3 domains). The temperature and enthalpy of melting of CH2 domains coincide in all the samples studied despite heterogeneity of the carbohydrate moiety. Thus, it may be postulated that the conservative part of CH2 domains makes a cardinal contribution to the interaction of these domains with the carbohydrate moiety.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9548942     DOI: 10.1021/bi972647a

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

1.  Design of therapeutic proteins with enhanced stability.

Authors:  Naresh Chennamsetty; Vladimir Voynov; Veysel Kayser; Bernhard Helk; Bernhardt L Trout
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-01       Impact factor: 11.205

2.  Activity-based assessment of an engineered hyperthermophilic protein as a capture agent in paper-based diagnostic tests.

Authors:  E A Miller; M W Traxlmayr; J Shen; H D Sikes
Journal:  Mol Syst Des Eng       Date:  2016-06-29

3.  Cold denaturation of monoclonal antibodies.

Authors:  Kristi L Lazar; Thomas W Patapoff; Vikas K Sharma
Journal:  MAbs       Date:  2010-01-27       Impact factor: 5.857

4.  Effect of ions on agitation- and temperature-induced aggregation reactions of antibodies.

Authors:  R Matthew Fesinmeyer; Sabine Hogan; Atul Saluja; Stephen R Brych; Eva Kras; Linda O Narhi; David N Brems; Yatin R Gokarn
Journal:  Pharm Res       Date:  2008-12-23       Impact factor: 4.200

5.  General mechanism for modulating immunoglobulin effector function.

Authors:  Peter Sondermann; Andrew Pincetic; Jad Maamary; Katja Lammens; Jeffrey V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-22       Impact factor: 11.205

6.  Investigating monoclonal antibody aggregation using a combination of H/DX-MS and other biophysical measurements.

Authors:  Roxana E Iacob; George M Bou-Assaf; Lee Makowski; John R Engen; Steven A Berkowitz; Damian Houde
Journal:  J Pharm Sci       Date:  2013-10-17       Impact factor: 3.534

7.  Stabilisation of the Fc fragment of human IgG1 by engineered intradomain disulfide bonds.

Authors:  Gordana Wozniak-Knopp; Johannes Stadlmann; Florian Rüker
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

8.  Three-dimensional structure of the human myeloma IgG2.

Authors:  Sergey Ryazantsev; Vladimir Tischenko; Christopher Nguyen; Vyacheslav Abramov; Vladimir Zav'yalov
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

9.  The reduced form of the antibody CH2 domain.

Authors:  Zhaoyong Xi; Xianglei Liu; Rui Lin; John D Persons; Tatiana V Ilina; Wei Li; Dimiter S Dimitrov; Rieko Ishima
Journal:  Protein Sci       Date:  2021-06-16       Impact factor: 6.993

10.  Production and characterization of specific monoclonal antibodies binding the Plasmodium falciparum diagnostic biomarker, histidine-rich protein 2.

Authors:  Chiuan Herng Leow; Martina Jones; Qin Cheng; Stephen Mahler; James McCarthy
Journal:  Malar J       Date:  2014-07-18       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.